Article Versions Notes

Kamo N, Furukawa S, Kato A, Yoshida K, Okabe C, Miura H, Sato T, Suzuki H, Soeda S, Fujimori K. Treatment Selection Based on Dominant Tumor Biology in Endometrial Carcinoma with Choriocarcinomatous Differentiation: A Case-Based Review. Current Oncology. 2026; 33(5):251. https://doi.org/10.3390/curroncol33050251

Kamo, Norihito, Shigenori Furukawa, Asami Kato, Keisuke Yoshida, Chikako Okabe, Hideki Miura, Tetsu Sato, Hiroshi Suzuki, Shu Soeda, and Keiya Fujimori. 2026. "Treatment Selection Based on Dominant Tumor Biology in Endometrial Carcinoma with Choriocarcinomatous Differentiation: A Case-Based Review" Current Oncology 33, no. 5: 251. https://doi.org/10.3390/curroncol33050251

Kamo, N., Furukawa, S., Kato, A., Yoshida, K., Okabe, C., Miura, H., Sato, T., Suzuki, H., Soeda, S., & Fujimori, K. (2026). Treatment Selection Based on Dominant Tumor Biology in Endometrial Carcinoma with Choriocarcinomatous Differentiation: A Case-Based Review. Current Oncology, 33(5), 251. https://doi.org/10.3390/curroncol33050251